Back to MORGAN STANLEY MORGAN STANLEY

GYREGYRE
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in GYRE THERAPEUTICS INC

MORGAN STANLEY holds 41,691 shares of GYRE (GYRE THERAPEUTICS INC), worth $274,743 as of 2026-Q2. The position was increased (+382.5% shares).

Current Value

$274,743

Current Shares

41,691

Total Value Change

+$46,240

Total Shares Change

+23,469

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
41,691
+382.5%
$274,7430.0%$6.59
26
2026-Q1
Decreased
8,641
-84.1%
$60,2270.0%$7.90
0
2025-Q4
Increased
54,498
+506.8%
$384,7570.0%$7.02
26
2025-Q3
Decreased
8,981
-74.5%
$66,9990.0%$7.50
0
2025-Q2
Increased
35,258
+151.3%
$259,1460.0%$7.42
25
2025-Q1
Decreased
14,030
-8.0%
$108,3110.0%$9.11
0
2024-Q4
Decreased
15,241
-16.4%
$184,4160.0%$12.66
0
2024-Q3
Increased
18,222
+150.5%
$228,5030.0%$12.76
25

Other major holders of GYRE: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used